Bloomberg
Wojcicki, Branson on 23andMe Going Public Via SPAC
Feb.04 -- 23andMe Inc. Chief Executive Officer Anne Wojcicki and billionaire Richard Branson explain why the DNA-testing company entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company (SPAC) founded...
Bloomberg
Soon-Shiong Sees T-Cell Booster as Covid Answer
Aug.19 -- Biotech billionaire Dr. Patrick Soon-Shiong, founder of ImmunityBio Inc., says just trying to block Covid with an antibody is insufficient. ImmunityBio is developing a vaccine called hAd5 that’s intended to specifically...
Bloomberg
Apollo to Buy Stake in Sofinnova
Apollo announced Monday it's acquiring a minority equity interest in Sofinnova Partners. Sofinnova Partners CEO Antoine Papiernik talked about the deal on "Bloomberg Markets: Americas" with Alix Steel and Guy Johnson.
Bloomberg
RockCreek Co-CIO on US Markets
Alifia Doriwala, Co-CIO at RockCreek, discusses her US market outlook and investment strategies. She speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Australia".
Bloomberg
Ebola Patient Dies in Nebraska
Nov. 17 -- Bloomberg's Erik Schatzker reports on today's top stories on Market Makers. (Source: Bloomberg)
Bloomberg
Bring Health to Your Portfolio With Pharma ETFs
July 1 -- Bloomberg Intelligence's Eric Balchunas examines investment opportunities in pharma ETFs. He speaks on "Bloomberg Markets."
Bloomberg
Is There a Buying Opportunity in Volatile Markets?
Feb. 25 -- Perceptive Advisors Founder and CEO Joseph Edelman and Skybridge Capital Co-Managing Partner and CIO Ray Nolte discuss their investment strategies. They speak on "Bloomberg ‹GO›."
Bloomberg
Why Are Market Bulls Shrugging Off Geopolitical Events?
July 21 -- Lew Piantedosi, Eaton Vance portfolio manager, discusses the performance of global stocks with Bloomberg's Vonnie Quinn and David Gura on "Bloomberg Markets."
Bloomberg
Qiming Venture's Kuang Likes Healthcare, Bio Tech
Jun.25 -- As part of our Venture China series, Qiming Venture Partners founding partner Duane Kuang told Bloomberg's Tom Mackenzie where he sees opportunities.
Bloomberg
Gingko Bioworks CEO Explains the Tech Around Legalized Cannabis
Sep.07 -- Jason Kelly, Gingko Bioworks Inc. chief executive officer, discusses the technology around legalized cannabis with Bloomberg's Emily Chang on "Bloomberg Technology."
Bloomberg
Investment Into the U.S. in AI, Biotech Has Dropped, Says Qiming Venture's Leung
Jan.14 -- Nisa Leung, managing partner at Qiming Venture Partners, discusses how the U.S.-China trade war impacts her investments in China and what's in the IPO pipeline. She speaks on "Bloomberg Markets: Asia" from the sidelines of the...
Bloomberg
What to Watch in U.S. Stocks Ahead of Earnings Season
Jul.11 -- David Keller, Sierra Alpha Research chief strategist, takes a look at the performance of markets just ahead of the U.S. corporate earnings season. He speaks with Bloomberg's Abigail Doolittle on "What'd You Miss?"
Bloomberg
Biotech in China Is Just Getting Started, Says Loncar Investments’s CEO
Mar.22 -- Brad Loncar, chief executive officer at Loncar Investments, discusses investing in China’s biotech sector and which companies he likes. He speaks on “Bloomberg Markets: China Open.”
Bloomberg
ETF Growth Opportunities in Chinese Biotech
Jun.19 -- Bloomberg's Eric Balchunas and Scarlet Fu break down the Loncar China Biopharma ETF (ticker: CHNA) with Brad Loncar, CEO of Loncar Investments. They discuss growth prospects in the space.
Bloomberg
Bloomberg Market Wrap 11/22: Trade Optimism, Biotech Hits 52-Week High
Nov.22 -- Bloomberg market reporters take a deep dive into all of today's action.
Bloomberg
Centene Will See Some 'Choppiness' This Quarter Due to Virus, CEO Says
Mar.12 -- Michael Neidorff, Centene Corp. chief executive officer, discusses the impact of the coronavirus outbreak on the company's earnings with Bloomberg's Romaine Bostick and Scarlet Fu on "Bloomberg Markets: The Close."
Curated Video
Biotech Company Working On Coronavirus Antibody Detection Patch, Beads
Researchers are developing two different products — a temporary patch and tiny injectable beads.
Curated Video
U.K. Readies For Vaccination Rollout
The United Kingdom will administer the first doses of a COVID-19 vaccine on Tuesday.
Bloomberg
SoftBank Said to Build $5 Billion Stake in Roche
Aug.03 -- Bloomberg has learned that SoftBank Group Corp. has built a $5 billion stake in Roche Holding AG, placing a big bet on the pharma giant’s strategy of using data to develop drugs. We’ve also learned that Nvidia Corp.’s $40...
Bloomberg
HKEX CEO: H.K. Unlikely to Get Advantage in China Data Reviews
Sep.01 -- Nicolas Aguzin, executive director and chief executive officer at Hong Kong Exchanges & Clearing, discusses Hong Kong’s biotech IPO pipeline, the possibility of a bubble in the sector and what he’s seeing from Chinese companies...
Bloomberg
Valeant Left Out, Actavis Acquires Allergan in $66B Deal
Nov. 17 -- Actavis is acquiring Allergan in a $66 billion deal that is valued at $219 per share, topping a bid from Valeant Pharmaceuticals after the companys chief executive officer declined to try to better the offer. Bloomberg's...
Bloomberg
What Are The Best ETFs of 2014?
Dec. 19 ""Bloomberg's Eric Balchunas discusses the best equity, fixed income, emerging markets and international ETF in On The Markets. He speaks with Bloomberg's Julie Hyman on Street Smart. (Source: Bloomberg)
Bloomberg
Donald Trump's Election Win Has Big Impact on ETFs
Nov. 11 -- Bloomberg's Eric Balchunas reports on the performance of ETFs after Donald Trump's U.S. election win. Balchunas speaks on "Bloomberg Markets."